Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
- Status
- COMPLETED
- Phase
- NA
Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE3
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
- Status
- TERMINATED
- Phase
- PHASE2
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE3
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)
- Status
- TERMINATED
- Phase
- PHASE2
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
- Status
- COMPLETED
- Phase
- PHASE2